Why is 3B Blackbio falling/rising?

As of 08-Jul, 3B Blackbio DX Ltd is experiencing a decline in its stock price, currently at 1,599.00, which reflects a decrease of 14.5 or 0.9%. The stock has shown a trend reversal after three consecutive days of gains, indicating a potential shift in investor sentiment. Despite today's performance being in line with the sector, the stock's moving averages suggest it is currently lower than the 50-day, 100-day, and 200-day moving averages, which may signal a bearish trend. Over the past week, the stock has increased by 8.78%, but it has seen a slight decline of 0.98% over the past month. Positive factors include a low debt-to-equity ratio and healthy long-term growth, with operating profit growing at an annual rate of 41.02%. However, negative factors such as flat results in March, a high price-to-book value, and minimal domestic mutual fund ownership may be contributing to the stock's current downward movement.
In the broader market context, while the stock has outperformed the benchmark Sensex over the past year with a return of 32.08% compared to the Sensex's 4.69%, it has underperformed in the short term, with a decline of 0.98% over the past month against the Sensex's increase of 1.85%. This disparity may reflect investor caution regarding the company's recent financial performance, particularly the significant drop in profit before tax and operating profit margins. The limited participation from domestic mutual funds could also indicate a lack of confidence in the stock's valuation, further impacting its price movement.